The test-negative design has become a standard approach for vaccine effectiveness studies. However, previous studies suggested that it may be more sensitive than other designs to misclassification of disease outcome caused by imperfect diagnostic tests. This could be a particular limitation in vaccine effectiveness studies where simple tests (e.g. rapid influenza diagnostic tests) are used for logistical convenience. To address this issue, we derived a mathematical representation of the test-negative design with imperfect tests, then developed a bias correction framework for possible misclassification. Test-negative design studies usually include multiple covariates other than vaccine history to adjust potential confounders; our methods can also address multivariate analyses and be easily coupled with existing estimation tools. We validated the performance of these methods using simulations of common scenarios for vaccine efficacy and were able to obtain unbiased estimates in a variety of parameter settings.
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Following the approach of Haber et al. (2015) [13], we consider four steps in the case reporting process: vaccination, 44 onset of symptoms, seeking of medical care, and diagnosis. For simplicity, let us assume that occurrence of TD and ND 45 are mutually independent, where their prevalences are represented as r 1 and r 0 , respectively 1 . Let v be the vaccination 46 coverage; in observational studies, vaccinated and unvaccinated population can have different likelihoods of seeking medical treatment (we denote such probabilities as m V and m U , respectively). As our focus in the present study is the 48 bias in VE estimation caused by imperfect tests, we made two key assumptions following Haber et al [13] : vaccination 49 does not affect the risk of ND or the relative probability µ of medical attendance between TD and ND (which may 50 reflect different disease severity between TD and ND). Namely, the study was assumed to be able to provide an unbiased 51 VE estimate if tests are perfect. Based on these assumptions, we can classify the expected incidence in population N 52 into four categories:
where α and β are the sensitivity and specificity of the test, respectively. Denoting observed case counts with 59 misclassification by X and Y , the process of diagnosis can be represented by the following matrix expression:
(1)
describes the conversion from the true disease state to the observed result. We hereafter 61 refer to C as the classification matrix.
62
The observed odds ratio (subject to the misclassification bias) is therefore given as
where δ = r1µ r0 is the odds of the (medically-attended) target disease in the unvaccinated population. 64 We define bias in the VE estimate to be the absolute difference between the (raw) estimate and the true value. The To develop a correction method that can address the bias presented in the previous section, we first model the case 85 reporting process in the univariate setting as follows. Let us assume that incidence of TD and ND both follow 86 Poisson-distributions. As presented in Section 2.1, the mean total incidence in the unvaccinated population is given The proportion of test positive patients in TND studies from systematic reviews. The proportions were retrieved from three systematic reviews [18, 19, 20] . (B) Estimated VE plotted against case ratio. Two sets of lines respectively correspond to different true VEs (80% and 40%, denoted by the dotted lines). The histogram in Panel (A) is overlaid on the x axis.
is obtained following this misclassified pattern, we can construct the likelihood of 93 obtaining such data, given underlying parameters, as
By maximising this likelihood over all parameters, we can obtain a maximum likelihood estimate (MLE) of the odds 95 ratio γ * that accounts for misclassfication. Let us refer to
as the "corrected odds ratio", which gives an unbiased estimate of γ. Comparing γ * with the the "raw" odds ratio
we find that the estimate can be corrected using the following substitution
where o α = 1−α α and o β = 1−β β are the odds of diagnostic errors corresponding to sensitivity and specificity, 99 respectively, which take 0 when sensitivity/specificity is perfect. Also note that the same odds ratio is obtained by 100 taking the odds ratio of the reconstructed data table where the inverted classification matrix is applied:
The determinant c = α + β − 1 is the Youden index of the test and satisfies 0 < c ≤ 1 (if c < 0, the test is not predictive 102 and the definitions of positive/negative should be swapped).
103 5 might need to be reconsidered.
108
The confidence interval for VE can be obtained by assuming log-normality of the odds ratio γ, i.e.,
where σ is the shape parameter of the log-normal distribution and is empirically given as
where π V and π U are observed (uncorrected) TD frequency ( We found that the uncorrected estimates, directly obtained from the raw case counts that were potentially misclassified, 120 exhibited substantial underestimation of VE for most parameter values ( Figure 3 ). On the other hand, our bias correction 121 method was able to yield unbiased estimates in every setting, whose median almost correspond to the true VE. Although 122 the corrected and uncorrected distributions were similar (with a difference in median ∼ 5%) when VE is relatively 123 low (40%) and the test has sufficiently high sensitivity and specificity (95% and 97%, respectively), they became 124 distinguishable with a higher VE (80%). With lower test performances, the bias in the VE estimates can be up to 125 10-20%, which may be beyond the level of acceptance in VE studies. 127 We have seen that the degree of bias for uncorrected VE estimates depends on parameter values. To explore the possible 128 degree of bias in existing VE studies, we extracted the reported crude VEs (i.e. VEs without adjustments of potential 129 confounders) from two systematic reviews [18, 20] (Young et al. [19] was not included because they did not report 130 case counts) and applied our bias correction method assuming different levels of test sensitivity and specificity. The case counts for each study summarised in the reviews were considered eligible for the analysis if the total sample size 132 exceeded 200. Varying the assumed sensitivity and specificity, we investigated the possible discrepancy between the 133 reported VE (or crude VE derived from the case counts if unreported in the reviews) and bias-corrected VE. We did not 134 consider correcting adjusted VEs because it requires access to the original datasets.
Bias correction of VEs reported in previous studies
135 Figure 4 displays the discrepancy between the reported VE and bias corrected VE corresponding to a range of 136 assumptions on the test performance. Many of the extracted studies employed polymerase chain reaction (PCR) 137 for the diagnostic test, which is expected to have a high performance. However, the true performance of PCR 138 cannot be definitively measured as there is currently no other gold-standard test available. Figure 4B suggests that 139 even a slight decline in the test performance can introduce a non-negligible bias in some parameter settings. Our 140 bias correction methods may therefore also be useful in TND studies using PCR, which would enable a sensitivity 141 analysis accounting for potential misdiagnosis by PCR tests. In this light, it is useful that the corrected odds ratio
is a monotonic function of both α and β (given that all the four components are positive). then be converted VE (in the logistic regression model, the linear coefficient for vaccination history corresponds to 151 log(1 − VE)).
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In this situation, the likelihood function now reflects a regression model and thus the bias-corrected estimate in the 153 univariate analysis (Equation (5)) is no longer applicable. We therefore need to develop a separate multivariate TND 154 study framework to correct for bias in multivariate analysis. Suppose that covariates ξ = (ξ 1 , ξ 2 , ..., ξ n ) are included 155 in the model, and that ξ 1 corresponds to vaccination history (1: vaccinated, 0: unvaccinated). ξ is expected to have a 156 certain distribution over the total population N , and let us denote the frequency density of covariates ξ by N (ξ), where 157 N (ξ)dξ = N . Let ρ 1 (ξ) and ρ 0 (ξ) be the conditional probabilities that an individual is included in the study with 158 TD and ND, respectively, given covariates ξ. Incorporating misclassification, the probability of an individual i with 159 covariates ξ i being included and tested positive/negative will be
Assuming that disease incidences follow Poisson distributions, as in the univariate case, we can obtain the probability
where λ + and λ − are the mean incidence of being included in the study and tested positive/negative: λ ± = it is often more convenient to model the binomial probability for the true outcome p 1 (ξ i ) = ρ1(ξi) ρ(ξi) and p 0 (
is the probability density of being included in the study given 169 covariates ξ, because the absolute scale of incidence is rarely of a primary concern. The binomial probabilities for the 170 respective observed outcomes (with errors) are then given by:
Let us use parameter set θ to model the binomial probabilities π + (and π − ) and assume that another set of parameters η 172 (nuisance parameters) characterise ρ(ξ i ). Then our objective is reduced to the estimation of θ and η.
173
Rearranging Equation (10), we get the joint likelihood for θ and η:
where λ(η) is the overall mean incidence: λ(η) = ρ(ξ; η)N (ξ)dξ. The factor outside the products on the right-hand 175 side of Eq. (12) is the probability that the study yields S subjects of which S + are positives and S − are negatives. The 176 first product is the probability density for covariates ξ i observed in data D, and the second product is the binomial 177 probabilities for the test results Z i . When only θ is of our concern, we can obtain the MLE for θ by maximising
as θ and η are separate in the likelihood (12). With the estimate θ * , the VE estimate for an individual with covariates 179 ξ 2:n = (ξ 2 , ξ 3 , ..., ξ n ) is given as (1 -odds ratio):
180 VE(ξ 2:n ) = 1 − p 1 (ξ 1 = 1, ξ 2:n ; θ * ) p 0 (ξ 1 = 1, ξ 2:n ; θ * ) p 1 (ξ 1 = 0, ξ 2:n ; θ * ) p 0 (ξ 1 = 0, ξ 2:n ; θ * ) .
(14)
Direct likelihood method for the logistic regression model 181
The logistic regression model is well-suited for modelling binomial probabilities p 1 and p 0 . The log-odds (log( p1 p0 )) is 182 characterised by a linear predictor as:
In the logistic regression model where covariate ξ 1 indicates vaccination history, the corresponding coefficient θ 1 184 gives the VE estimate: VE = 1 − exp(θ 1 ). Due to the assumed linearity, the estimated VE value is common across 185 individuals regardless of covariates ξ 2:n . 186 We can employ the direct likelihood method by combining Equations (13) and (15). The usual logistic regression 187 optimises θ by assuming that the test results follow Bernouli distributions Z i ∼ Bernouli(p 1 (ξ i ; θ)) (Z i = 1 for 188 positive test results and 0 for negative). To correct the misclassification bias, we instead need to use the modified 189 probabilities given by Eq. (11) to construct the likelihood accounting for diagnostic error, i.e.,
190
Z i ∼ Bernouli(π + (ξ i ; θ)) = Bernouli(αp 1 (ξ i ; θ) + (1 − β)p 0 (ξ i ; θ)). 
ϕ i+ andφ i− are estimated probabilities that the test result for individual i is incorrect (i.e., z i = Z i ) given Z i .
211
The sampling procedure (17) is therefore interpreted as the test result Z i being "flipped" at a probabilityφ i+ 212 orφ i− . Later we will discuss possible procedures to obtain these probabilities. The simplest option to estimateφ i± is to use Bayesian probability
The true binomial probabilities p 0 (ξ i ), p 1 (ξ i ) are not known, but their estimators are derived with the inverted 224 classification matrix in the same manner as Eq. (7). By substituting
These probabilities can be computed provided the odds of the test results π+(ξi) π−(ξi) . We employ a parametric approach and 226 approximate this odds by applying estimation tool M to the original data D; i.e., the predicted binomial probability 227 p 1 (ξ i ) obtained from D is used as a proxy of π + (ξ i ). Generally it is not assured that true and observed probabilities p 1 (ξ i ) and π + (ξ i ) have the same mechanistic structure captured by M ; however, when our concern is limited to 229 the use of model-predicted probabilities to smooth the data D, we may expect for M to provide a sufficiently good 230 approximation with realistic test sensitivity and specificity. The above framework can be regarded as a variant of 231 parametric bootstrapping methods as MO datasets are generated from data D assuming a parametric model M . The 232 whole bias correction procedure is presented in pseudocode (Algorithm 1); a sample R code is also available on GitHub 233 (https://github.com/akira-endo/TND-biascorrection/).
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Algorithm 1 Multiple imputation with parametric bootstrapping
..S Fit model M to D to obtain a predictive model π + =p 1 (ξ) for j = 1, 2, ..., J do for i = 1, ..., S do π + ←p 1 (ξ i ) Predict the binomial probability π + by model M z j i ← Z i Copy Z i , and then flip at a probability ϕ to imputez j iterations (see the supplementary document for details). However, in our simulation we found that the performance 237 of EM algorithm was inferior to the other two alternatives (direct likelihood and parametric bootstrapping). The 238 three methods all provided effectively identical distributions of estimates in most settings, but in some settings the 239 EM algorithm produced extreme estimates (VE < 0 or > 1) slightly more often than the other two. We therefore 240 recommend parametric bootstrapping as the first choice of bias correction method when the direct likelihood approach 241 is inconvenient. To assess the performance of this method, we used the same simulation framework as in the univariate analysis (Table   244 1). In addition to vaccination history (denoted by ξ 1 ), we consider one categorical and one continuous covariate. Let us 245 assume that ξ 2 represents the age group (categorical; 1: child, 0: adult) and ξ 3 the pre-infection antibody titre against 246 TD (continuous). Suppose that the population ratio between children and adults is 1:2, and that ξ 3 is scaled so that 247 it is standard normally distributed in the population. For simplicity, we assumed that all the covariates are mutually 248 independent with regard to the distribution and effects (i.e., no association between covariates and no interaction effects).
249
The relative risk of children was set to be 2 and 1.5 for TD and ND, respectively, and a unit increase in the antibody 250 titre was assumed to halve the risk of TD (and not to affect the risk of ND). The mean total sample size λ was set 251 to be 3,000, and 500 sets of simulation data were generated for each scenario. VE estimates were corrected by the 252 parametric bootstrapping approach (the number of iterations J = 100) and were compared with the raw (uncorrected) 253 VE estimates. 254 Figure 6 : Uncertainty in VE estimates obtained from the true/misclassified datasets in the multivariate setting. The distributions of VE estimates from the simulated true (yellow) and misclassified (light blue) data are shown. The direct likelihood method was employed to correct biases in the misclassified data.
A", "continuous variable B", ...) whose distribution and effect were identical to "age" (for categorical variables) and 1, 1, 1) ), 280 we employed two more scenarios with a larger number of covariates: (1, 3, 3) and (1, 5, 5).
281
The simulation results are presented in Figure 7 . Overall, additional confounding variables led to more severe bias in 282 the uncorrected VE estimates towards underestimation. As shown in Figure 2A , the degree of bias is strongly affected 283 by the case ratio: the ratio between the risk of TD and ND. More confounding variables in a population result in higher 284 heterogeneity in individuals' risk of TD and ND. This may account for the association between the degree of bias and 285 the number of confounding variables; more individuals in a highly heterogeneous population may fall in the outer range 286 of the case ratio shown in Figure 2A , substantially contributing to the misclassification bias. Misclassification caused by imperfect diagnostic tests can potentially lead to substantial biases in TND studies. By 289 considering the processes involved in VE estimation, we have characterised the degree of bias potentially caused 290 by diagnostic misclassification in different parameter settings, finding that VE can be noticeably underestimated, 291 particularly when the ratio between TD and ND cases in the study data is unbalanced. To address this potential bias, we 292 developed multiple bias correction methods that address test misclassification and provide unbiased VE estimates in 293 both univariate and multivariate settings. When the test sensitivity and specificity are known or assumed, those values 294 can be used to restore the true VE estimate by a relatively simple statistical procedure. Using simulations, we showed 295 that our methods could successfully eliminate the bias in VE estimates obtained from misclassified data, although some 296 uncertainty was introduced as a result of the information loss. 297 We believe that our methods could therefore enable researchers to address possible misclassification in their data 298 and report unbiased VE estimates even when imperfect tests had to be used. Such methods could also help in the 
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For mathematical convenience, we change the variable λ V to λ V = 1+γδ 1+δ λ V . Let l = log L(γ, δ, λ V , λ U ; X). Partial 371 derivatives of l are
Equation (21) gives the maximum likelihood estimates:
The confidence intervals for parameters can be constructed using the Fisher's information matrix from Equation (21). 
We log-transform γ and δ for mathematical convenience. Noting that ∂y ∂(log x) = x ∂y ∂x , we get
With the parameter values estimated in Eq. (22), we get the following information matrix
and y ξ = 1 c [αY ξ − (1 − α)X ξ ] are the true case counts (without misclassification) 378 for ξ = V, U . Let p V = x V /(x V + y V ) and p U = x U /(x U + y U ) be the corresponding true binomial probabilities.
We can relate this to the true standard error that would be obtained with perfect tests,
or to the observed standard error (without correction),
382
SD(log γ raw ) = 1
where σ V = [p V (1 − p V )] −1/2 and σ U = [p U (1 − p U )] −1/2 are the components of the true standard error and 383 Σ V = [π V (1 − π V )] −1/2 and Σ U = [π U (1 − π U )] −1/2 are those of uncorrected standard error. We get 384 σ * = SD(log(γ * )) = σ 2
This equation indicates that the confidence intervals diverge when the true outcome is bipolarised (p V , p U 0 or 1).
